Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.
AUTOR(ES)
Galea-Debono, A
RESUMO
It has been suggested that the therapeutic response to levodopa in patients with Parkinson's disease may be related to changes in plasma growth hormone concentration. In order to examine this problem, we have determined plasma DOPA and growth hormone levels after a standard oral levodopa load in 32 patients with Parkinson's disease. Levodopa caused an increase in plasma growth hormone concentration in 30 subjects. The magnitude and timing of this growth hormone response was not related to the clinical response, the presence or absence of response swings, or the occurrence of dyskinesias. The growth hormone response to levodopa is normal in patients with Parkinson's disease and not altered by long-term levodopa treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492632Documentos Relacionados
- Phenytoin-induced increase in growth hormone response to levodopa in adult males.
- Altered thalamic response to levodopa in Parkinson’s patients with dopa-induced dyskinesias
- Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
- The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man
- Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
